At risk for syphilis or chlamydia? There’s a PEP for that
Doxycycline may be the next frontier for queer men and trans women at high risk for certain STIs.
March 19 2024 12:04 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Doxycycline may be the next frontier for queer men and trans women at high risk for certain STIs.
A new study delves into how stem cell transplantation can kill the virus behind AIDS.
Students in Philadelphia proved anybody has what it takes to be a scientist,
The drug clears toxic brain proteins and had positive results in mice.
A new study shows hope for the 10 percent of HIV-positive patients who cannot rely on initial treatment meds.
Nearly 30 percent of HIV-positive people develop the lung disease in their lifetime.
A new effort will help elderly people with HIV live healthier lives less impacted by chronic illness.
Recent research finds that periodic fasting-like diets can reduce a person's risk of disease and biological age.
Many scientists are undeterred in the effort to prevent HIV without a lifetime of medication.
Young people are driving the reduction.
Smoking is particularly dangerous for people living with HIV.
Kundai Chinyenze leads a global initiative that refuses to stop until a vaccine is found.
A new study indicates that some children with HIV were found to have lower auditory responses than those without.
A study involving macaques showed the injectable implant as fully effective at preventing HIV.
A study in HIV-positive humanized mice was 60 percent effective as opposed to the 29 percent efficacy in previous studies.
Researchers will study benefits and cognitive decline among people living with HIv.
The plant-based compound could be a potential HIV treatment used in combination with ART.
The Phase 1 trial shows the new method could be a very viable option for preventing HIV transmission.
The first Phase 3 trial for a potential HIV vaccine has ended in disappointment.
The vaccine uses an engineered protein from within the virus.